MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

Pharmacists Express Concerns Over Placebo Pill for Children

— LONDON, June 16

LONDON, June 16 /PRNewswire/ -- Responding to reports in the media that Obecalp, a placebo pill for children, is due to be made available on the UK market, the Royal Pharmaceutical Society of Great Britain's (RPSGB) Chief Scientist, Jayne Lawrence said:

"The RPSGB is concerned that this product is due to be made available on the UK market as a placebo pill to give to children.

"As a dietary supplement, the manufacturers have not been required to carry out clinical trials. Further, the use of this drug indicates that symptoms diagnosis and advice have not been sought from a qualified healthcare professional, which runs the risk of misdiagnosis.

"We are also concerned that giving a child the pill reinforces the wrong message - that tablets are the answer for all of life's aches and pains."

Pharmacists are trained healthcare professionals and are experts in medicines management. They can offer comprehensive advice on a range of common illnesses and suitable medication if necessary. Pharmacists have significant healthcare knowledge and will refer patients to their GP when necessary.

Notes to Editors:

The Royal Pharmaceutical Society of Great Britain (RPSGB) is the professional and regulatory body for pharmacists in England, Scotland and Wales. It also regulates pharmacy technicians on a voluntary basis, which is expected to become statutory under anticipated legislation. The primary objectives of the RPSGB are to lead, regulate, develop and represent the profession of pharmacy.

The RPSGB leads and supports the development of the profession within the context of the public benefit. This includes the advancement of science, practice, education and knowledge in pharmacy. In addition, it promotes the profession's policies and views to a range of external stakeholders in a number of different forums. Following the publication in 2007 of the Government White Paper Trust, Assurance and Safety - The Regulation of Health Professionals in the 21st Century, the RPSGB is working towards the demerger of its regulatory and professional roles. This will see the establishment of a new General Pharmaceutical Council and a new professional body for pharmacy in 2010.

Related news

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us